Perspectives in Clinical Research
Table of Contents
2018| April-June | Volume 9 | Issue 2
Please wait, loading Google Map...
| EDITORIAL | ||
| Research methodology workshops: A small step towards practice of evidence-based medicine | p. 59 | |
| Nithya Jaideep Gogtay | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| OPINION |  |
|
| Real world evidence (RWE) - Are we (RWE) ready? | p. 61 | |
| Viraj Ramesh Suvarna | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| ORIGINAL ARTICLES | |
|
| Payment for participation in clinical research: Review of proposals submitted to the ethics committees | p. 64 | |
| Padmaja A Marathe, Raakhi K Tripathi, Yashashri C Shetty, Sunil S Kuyare, Sandhya K Kamat, Urmila M Thatte | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
 |
An analysis of adverse drug reactions in extremes of age group at tertiary care teaching hospital | p. 70 |
| Saloni Amin, Samidh Shah, Mira Desai, Asha Shah, KM Maheriya | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
 |
Drug prescription behavior: A cross-sectional study in public health facilities in two states of North India | p. 76 |
| Jaya Prasad Tripathy, Pankaj Bahuguna, Shankar Prinja | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| Assessment of change in knowledge about research methods among delegates attending research methodology workshop | p. 83 | |
| Manisha Shrivastava, Nehal Shah, Seema Navaid | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| ETHICS EDUCATION | |
|
| Monitoring of approved studies: A difficult tightrope walk by Ethics Committees | p. 91 | |
| Sanish Davis | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| INVESTIGATOR INSIGHTS | |
|
| Investigator preparedness for monitoring and audits | p. 95 | |
| Renju Ravi, Debdipta Bose, Nithya J Gogtay, Urmila M Thatte | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| STATISTICS | |
|
| Understanding the properties of diagnostic tests – Part 2: Likelihood ratios | p. 99 | |
| Priya Ranganathan, Rakesh Aggarwal | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| PHARMACOVIGILANCE PERSPECTIVE | |
|
| Analysis of serious adverse event: Writing a narrative | p. 103 | |
| Indu Nambiar | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| LETTERS TO EDITOR | |
|
| Antidiabetic medication and quality of life: A comment on Chaturvedi et al. (2018) | p. 107 | |
| Saurav Basu | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| Author's reply | p. 108 | |
| Chetna Desai | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||